{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:47:33Z","timestamp":1794030453918,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cyto.2025.157002","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:55:03Z","timestamp":1753912503000},"page":"157002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Genetic polymorphisms of IFNL3 are associated with risk of immune checkpoint inhibitor-related pneumonitis in lung cancer patients"],"prefix":"10.1016","volume":"194","author":[{"given":"Shengzu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2025.157002_bb0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chest.2021.02.032","article-title":"Immune checkpoint inhibitor-related pneumonitis in lung Cancer: real-world incidence, risk factors, and management practices across six health care Centers in North Carolina","volume":"160","author":"Atchley","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cyto.2025.157002_bb0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139481","article-title":"Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD","volume":"131","author":"Benjamin","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cyto.2025.157002_bb0015","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2025.157002_bb0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cyto.2025.157002_bb0025","article-title":"Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy","volume":"32","author":"Caliman","year":"2022","journal-title":"Cancer Treat Res. Commun."},{"key":"10.1016\/j.cyto.2025.157002_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.779691","article-title":"Risk factors and biomarkers for immune-related adverse events: a practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors","volume":"13","author":"Chennamadhavuni","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157002_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/JLB.3A0120-001RRR","article-title":"Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-\u03bb3 or IFN-\u03bb4 show distinct phenotypes","volume":"110","author":"De","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157002_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.2100707","article-title":"Beyond good and evil: molecular mechanisms of type I and III IFN functions","volume":"208","author":"Dowling","year":"2022","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2025.157002_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41571-020-0352-8","article-title":"Moving towards personalized treatments of immune-related adverse events","volume":"17","author":"Esfahani","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cyto.2025.157002_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104591","article-title":"Recent advances in the study of immune checkpoint inhibitor-associated pneumonia","volume":"206","author":"Feng","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157002_bb0055","first-page":"2.12.1","article-title":"SNP genotyping using the sequenom MassARRAY iPLEX platform","volume":"60","author":"Gabriel","year":"2009","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"5","key":"10.1016\/j.cyto.2025.157002_bb0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"issue":"41","key":"10.1016\/j.cyto.2025.157002_bb0065","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.vaccine.2016.08.073","article-title":"Antibodies to HBV surface antigen in relation to interferon-\u03bb3 in hemodialysis patients","volume":"34","author":"Grzegorzewska","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2025.157002_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110732","article-title":"Neoadjuvant immune-checkpoint inhibitors in lung cancer - a primer for radiologists","volume":"161","author":"Kifjak","year":"2023","journal-title":"Eur. J. Radiol."},{"issue":"284","key":"10.1016\/j.cyto.2025.157002_bb0075","doi-asserted-by":"crossref","first-page":"284ra259","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cyto.2025.157002_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.157002_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1345971","article-title":"Intratumoral IL-28B gene delivery elicits antitumor effects by Remodeling of the tumor microenvironment in H22-bearing mice","volume":"2022","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cyto.2025.157002_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/796461","article-title":"IFN-\u03bb: a new class of interferon with distinct functions-implications for hepatitis C virus research","volume":"2015","author":"Liu","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"3","key":"10.1016\/j.cyto.2025.157002_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/imm.13181","article-title":"HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages","volume":"160","author":"Liu","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2025.157002_bb0100","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3389\/fphar.2018.01430","article-title":"The relative risk and incidence of immune checkpoint inhibitors related pneumonitis in patients with advanced Cancer: a Meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157002_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12957-022-02695-y","article-title":"Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1\/PD-L1 inhibitors: a retrospective analysis","volume":"20","author":"Ma","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.cyto.2025.157002_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118384","article-title":"IL-27 along with IL-28B ameliorates the pulmonary redox impairment, inflammation and immunosuppression in benzo(a)pyrene induced lung cancer bearing mice","volume":"260","author":"Majumder","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2025.157002_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109807","article-title":"Mechanistic insight into the synergism of IL-27 and IL-28B in regulation of benzo(a)pyrene-induced lung carcinogenesis associated ROS\/NF-\u03baB\/NLRP3 crosstalk","volume":"354","author":"Majumder","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.cyto.2025.157002_bb0120","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.157002_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105779","article-title":"Interferon lambda receptor-1 isoforms differentially influence gene expression and HBV replication in stem cell-derived hepatocytes","volume":"221","author":"Novotny","year":"2024","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.cyto.2025.157002_bb0130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","volume":"63","author":"O\u2019Brien","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cyto.2025.157002_bb0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00228-024-03647-z","article-title":"Immune-related serious adverse events with immune checkpoint inhibitors: systematic review and network meta-analysis","volume":"80","author":"Oliveira","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cyto.2025.157002_bb0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fimmu.2017.00621","article-title":"Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2025.157002_bb0145","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2589-7500(23)00082-1","article-title":"Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study","volume":"5","author":"Saad","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"3","key":"10.1016\/j.cyto.2025.157002_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020029692","article-title":"Association of Interleukin 28B polymorphism with clearance of hepatitis C virus: a Mini review","volume":"30","author":"Shaheen","year":"2020","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"4","key":"10.1016\/j.cyto.2025.157002_bb0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4149\/av_2015_04_413","article-title":"Protective efficacy of IFN-\u03c9 AND IFN-\u03bbs against influenza viruses in induced A549 cells","volume":"59","author":"\u0160korvanov\u00e1","year":"2015","journal-title":"Acta Virol."},{"key":"10.1016\/j.cyto.2025.157002_bb0160","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4149","article-title":"Association between genetic polymorphisms of the IL28B gene and leukomonocyte in Chinese hepatitis B virus-infected individuals","volume":"5","author":"Song","year":"2017","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.cyto.2025.157002_bb0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2011.11.025","article-title":"Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B","volume":"142","author":"Sonneveld","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cyto.2025.157002_bb0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1759-7714.13240","article-title":"Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis","volume":"11","author":"Wang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.cyto.2025.157002_bb0175","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2147\/OTT.S104904","article-title":"Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:41:50Z","timestamp":1762353710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"alternative-id":["S1043466625001498"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157002","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms of IFNL3 are associated with risk of immune checkpoint inhibitor-related pneumonitis in lung cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157002"}}